DNA X, Inc.: cashflow_operating
| Value | {"amount": -10137000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-09-30 |
| Status | current |
| Entity | DNA X, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:51:55.460363+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/fa8300f2-9dd0-4332-91b7-43068893aa1f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001493152-23-041079 · Open the official SEC filing →Retrieved: 2026-08-19T11:51:55.460363+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001178697/cashflow-operating/2022-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/fa8300f2-9dd0-4332-91b7-43068893aa1f
History
- supersedes {"amount": -10139000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} (evidence 0001493152-22-031695)